CXCL4-induced TLR9 impairment in B cells from SSc patients also likely results in the secretion of autoantibodies targeting topoisomerase I or centromere proteins, both of which bind dsDNA in patients with diffuse or limited SSc, respectively. This evidence concerns the gene PF4 and systemic sclerosis.